Filing Details

Accession Number:
0001181431-12-004490
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-01-30 18:09:56
Reporting Period:
2012-01-26
Filing Date:
2012-01-30
Accepted Time:
2012-01-30 18:09:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325879 Aveo Pharmaceuticals Inc AVEO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1241221 Tuan Ngoc Ha C/O Aveo Pharmaceuticals, Inc.
75 Sidney Street
Cambridge MA 02139
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-09-08 18,349 $0.00 103,741 No 4 J Direct
Common Stock Disposition 2011-09-08 18,349 $0.00 151,980 No 4 J Indirect Held by GRAT
Common Stock Disposition 2012-01-26 4,613 $13.37 99,639 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Direct
No 4 J Indirect Held by GRAT
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 151,980 Indirect Held by GRAT
Footnotes
  1. The increase of shares of directly held common stock was due to a distribution from Tuan Ha-Ngoc 2009 GRAT to the reporting person on 09/08/2011.
  2. The decrease of shares of indirectly held common stock was due to a distribution from Tuan Ha-Ngoc 2009 GRAT to the reporting person on 09/08/2011.
  3. Shares are held by Gabriel Schmergel, Trustee, or his successor in trust, of the Tuan Ha-Ngoc 2009 GRAT. Mr. Schmergel is trustee of the Tuan Ha-Ngoc 2009 GRAT and he exercises sole voting and investment power over the shares held of record by such trust. Mr. Ha-Ngoc disclaims beneficial ownership over all such shares, except to the extent of his pecurniary interest therein.
  4. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2011, which was implemented to cover taxable events related to the partial vesting of certain restricted stock.
  5. Includes 988 shares acquired on June 30, 2011 under the AVEO Pharmaceuticals, Inc. Employee Stock Purchase Plan.
  6. Includes 511 shares acquired on December 31, 2011 under the AVEO Pharmaceuticals, Inc. Employee Stock Purchase Plan.